Literature DB >> 7379334

Transfer factor: failure to transfer reactivity in normal human subjects.

L E Spitler.   

Abstract

Transfer factor was prepared from highly selected normal donors. One lot was made from donors strongly reactive to coccidioidin and negative to Dharmendra antigen in in vivo and in vitro testing. The other lot was made from donors without reactivity to coccidioidin and strongly reactive to Dharmendra. Aliquots of each lot were injected into eight normal recipients. Eight additional normal recipients were given placebo injections. Before and after injection, skin test reactivity and in vitro testing were evaluated by an individual who did not know which preparation the patient received. Changes in immunologic reactivity in subjects receiving transfer factor could not be distinguished from those in subjects receiving placebo. I conclude that transfer factor does not cause enhancement of immunologic reactivity in normal subjects. A well designed, critical study is needed to determine whether or not it does, in fact, cause enhancement of immunologic reactivity in patients with impaired cellular immune reactivity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7379334      PMCID: PMC1538135     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Suppression of cellular immune responses following transfer factor: report of a case.

Authors:  C H Kirkpatrick; J I Gallin
Journal:  Cell Immunol       Date:  1975-02       Impact factor: 4.868

2.  The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes.

Authors:  H S LAWRENCE
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

3.  Rosette-forming cells, immunologic deficiency diseases and transfer factor.

Authors:  J Wybran; A S Levin; L E Spitler; H H Fudenberg
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

4.  Immunologic specificity of transfer factor.

Authors:  K S Zuckerman; J A Neidhart; S P Balcerzak; A F LoBuglio
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

5.  Transfer factor therapy in immuno-deficiencies.

Authors:  C Griscelli; J P Revillard; H Betuel; C Herzog; J L Touraine
Journal:  Biomedicine       Date:  1973-05

6.  A placebo controlled clinical trial of transfer factor in lepromatous leprosy.

Authors:  W R Faber; D L Leiker; I M Nengerman; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

7.  Skin test conversion following transfer factor. A double-blinded study of normal individuals.

Authors:  J A Neidhart; N Christakis; E N Metz; S P Balcerzak; A F LoBuglio
Journal:  J Allergy Clin Immunol       Date:  1978-02       Impact factor: 10.793

8.  Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography.

Authors:  A A Vandenbark; D R Burger; D L Dreyer; G D Daves; R M Vetto
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

9.  The Wiskott-Aldrich syndrome. Results of transfer factor therapy.

Authors:  L E Spitler; A S Levin; D P Stites; H H Fudenberg; B Pirofsky; C S August; E R Stiehm; W H Hitzig; R A Gatti
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

10.  Effect of transfer factor on lymphocyte function in anergic patients.

Authors:  C H Kirkpatrick; R R Rich; T K Smith
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

View more
  2 in total

1.  Evidence for the presence of a low molecular-weight activator of suppressor monocytes (LASM) in dialysates of T lymphocytes.

Authors:  K Nekam; A J Strelkauskas; H H Fudenberg; G G Donnan; J M Goust
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

2.  Passive transfer of immunity to trichostrongyle species infections in sheep. Investigations of specificity and limitations of 'transfer factor' activity with Trichostrongylus axei infections.

Authors:  J G Ross; W G Halliday
Journal:  Vet Res Commun       Date:  1981-04       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.